Literature DB >> 7853795

Tubular basement membrane changes during induction and regression of drug-induced polycystic kidney disease.

F A Carone1, R J Butkowski, S Nakamura, M Polenakovic, Y S Kanwar.   

Abstract

Defective cell-extracellular matrix (ECM) biophysiology is considered a factor in the development of polycystic kidney disease (PKD). Altered biosynthesis of various ECM components may result in tubular dysmorphogenesis and uncontrolled tubular cystic expansion. In this study, expression of certain ECM components was investigated in a diphenylthiazole (DPT)-induced rat model of PKD. DPT induces cystic change in all the collecting tubules, most severe in the outer medulla and inner cortex, and following withdrawal of DPT, cystic tubules return to normal with persistence of focal interstitial fibrosis. SDS-PAGE analyses of isolated tubular basement membranes (TBMs) of control and PKD kidneys revealed overall similar electrophoretic migratory bands. However, in PKD, there were relative increases in components with M(r) approximately 380,000, 250,000 and 145,000, and a decrease in the component with M(r) approximately 55,000. Immunoblot analyses revealed that the major components of TBM (type-IV collagen, laminin beta 1 and beta 2 chains and entactin) were present in the same relative concentrations in control and PKD. The expression of tubulointerstitial (TIN) antigen was decreased. Also, the relative concentrations of type-I collagen and fibronectin were increased in the PKD group. Following recovery, the expressions of TIN and fibronectin returned to normal, whereas type-I collagen remained elevated. ELISA determinations revealed increased expression of interstitial collagens type-I, -V and -VI in PKD vs control and they remained elevated following recovery, while that of type-III was unchanged.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7853795     DOI: 10.1038/ki.1994.406

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Differential rescue of the renal and hepatic disease in an autosomal recessive polycystic kidney disease mouse mutant. A new model to study the liver lesion.

Authors:  B K Yoder; W G Richards; C Sommardahl; W E Sweeney; E J Michaud; J E Wilkinson; E D Avner; R P Woychik
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

2.  Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene.

Authors:  C Boulter; S Mulroy; S Webb; S Fleming; K Brindle; R Sandford
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

Review 3.  Polycystins as components of large multiprotein complexes of polycystin interactors.

Authors:  Emily Hardy; Leonidas Tsiokas
Journal:  Cell Signal       Date:  2020-04-17       Impact factor: 4.315

4.  Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.

Authors:  B Hocher; C Thöne-Reineke; P Rohmeiss; F Schmager; T Slowinski; V Burst; F Siegmund; T Quertermous; C Bauer; H H Neumayer; W D Schleuning; F Theuring
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

5.  The Jeremiah Metzger Lecture. Polycystic kidney disease: old disease in a new context.

Authors:  Jared J Grantham
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

6.  Polycystin-1 Regulates Actomyosin Contraction and the Cellular Response to Extracellular Stiffness.

Authors:  Elisa Agnese Nigro; Gianfranco Distefano; Marco Chiaravalli; Vittoria Matafora; Maddalena Castelli; Angela Pesenti Gritti; Angela Bachi; Alessandra Boletta
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.